Premium
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression
Author(s) -
Badar Talha,
Astle John,
Kakar Imran K.,
Zellner Katie,
Hari Parameswaran N.,
Hamadani Mehdi
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16738
Subject(s) - ibrutinib , medicine , bruton's tyrosine kinase , oncology , brentuximab vedotin , mantle cell lymphoma , transplantation , chronic lymphocytic leukemia , lymphoma , immunology , tyrosine kinase , leukemia , hodgkin lymphoma , receptor